Mark E. Smolkin

4.5k total citations
86 papers, 3.2k citations indexed

About

Mark E. Smolkin is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Mark E. Smolkin has authored 86 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 30 papers in Immunology and 24 papers in Molecular Biology. Recurrent topics in Mark E. Smolkin's work include Immunotherapy and Immune Responses (30 papers), vaccines and immunoinformatics approaches (17 papers) and T-cell and B-cell Immunology (14 papers). Mark E. Smolkin is often cited by papers focused on Immunotherapy and Immune Responses (30 papers), vaccines and immunoinformatics approaches (17 papers) and T-cell and B-cell Immunology (14 papers). Mark E. Smolkin collaborates with scholars based in United States, Qatar and Netherlands. Mark E. Smolkin's co-authors include Craig L. Slingluff, Gina R. Petroni, James W. Patterson, Kimberly A. Chianese‐Bullock, Donna H. Deacon, Lynn T. Dengel, Gulsun Erdag, William W. Grosh, Walter C. Olson and Sofia M. Shea and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Mark E. Smolkin

83 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Smolkin United States 34 1.5k 1.5k 939 461 388 86 3.2k
John C. Morris United States 35 1.6k 1.1× 1.5k 1.0× 1.0k 1.1× 484 1.0× 230 0.6× 115 3.3k
Pierpaolo Correale Italy 34 2.1k 1.4× 1.4k 1.0× 840 0.9× 769 1.7× 284 0.7× 159 3.7k
Rohit Jain United States 30 987 0.7× 1.2k 0.8× 827 0.9× 529 1.1× 902 2.3× 162 3.8k
Howard Streicher United States 27 1.8k 1.2× 1.2k 0.8× 910 1.0× 760 1.6× 201 0.5× 105 3.5k
Robert J. Hayashi United States 30 1.4k 0.9× 1.4k 0.9× 604 0.6× 554 1.2× 303 0.8× 109 4.2k
Manel Juan Spain 36 912 0.6× 1.7k 1.2× 827 0.9× 380 0.8× 418 1.1× 180 4.1k
Daniel H. Fowler United States 33 1.2k 0.8× 2.2k 1.5× 737 0.8× 293 0.6× 314 0.8× 140 4.2k
Kathleen M. Mahoney United States 20 2.1k 1.4× 1.6k 1.1× 938 1.0× 564 1.2× 191 0.5× 50 3.5k
Austin Miller United States 34 2.2k 1.4× 1.8k 1.2× 947 1.0× 936 2.0× 541 1.4× 136 4.6k
Santosha A. Vardhana United States 33 1.0k 0.7× 1.7k 1.2× 987 1.1× 306 0.7× 182 0.5× 86 3.8k

Countries citing papers authored by Mark E. Smolkin

Since Specialization
Citations

This map shows the geographic impact of Mark E. Smolkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Smolkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Smolkin more than expected).

Fields of papers citing papers by Mark E. Smolkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Smolkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Smolkin. The network helps show where Mark E. Smolkin may publish in the future.

Co-authorship network of co-authors of Mark E. Smolkin

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Smolkin. A scholar is included among the top collaborators of Mark E. Smolkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Smolkin. Mark E. Smolkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perry, Jeffrey J., Elizabeth M. Goldberg, Mary Ann Ryan, et al.. (2025). Prochlorperazine maleate versus placebo for the prophylaxis of acute mountain sickness: a double-blind randomized controlled trial. Journal of Travel Medicine. 32(5).
2.
Douville, Nicholas J., Michael R. Mathis, Mark E. Smolkin, et al.. (2025). Inspired Oxygen Concentration During the Re-initiation of Two-Lung Ventilation in Thoracic Surgery: A Post Hoc Analysis of Data From the Multicenter Perioperative Outcomes Group. Anesthesia & Analgesia. 141(3). 667–670.
3.
Meneveau, Max O., Gina R. Petroni, Kevin Lynch, et al.. (2021). Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist. Journal for ImmunoTherapy of Cancer. 9(5). e002214–e002214. 14 indexed citations
4.
Zaydfudim, Victor M., et al.. (2020). The impact of cirrhosis and MELD score on postoperative morbidity and mortality among patients selected for liver resection. The American Journal of Surgery. 220(3). 682–686. 12 indexed citations
5.
Howie, Heather L., Ariel Hay, Hayley R. Waterman, et al.. (2020). IgG Subclass Determines Suppression Versus Enhancement of Humoral Alloimmunity to Kell RBC Antigens in Mice. Frontiers in Immunology. 11. 1516–1516. 19 indexed citations
6.
Dillon, Patrick M., Gina R. Petroni, Mark E. Smolkin, et al.. (2017). A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer. Journal for ImmunoTherapy of Cancer. 5(1). 92–92. 50 indexed citations
7.
8.
Wages, Nolan A., et al.. (2015). Tubular carcinoma of the breast: Institutional and SEER database analysis supporting a unique classification. Breast Disease. 35(2). 103–111. 10 indexed citations
9.
10.
Hu, Yinin, Gina R. Petroni, Walter C. Olson, et al.. (2014). Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine. Cancer Immunology Immunotherapy. 63(8). 779–786. 23 indexed citations
11.
Slingluff, Craig L., Gina R. Petroni, David L. Brautigan, et al.. (2013). Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47). Clinical Cancer Research. 19(13). 3611–3620. 28 indexed citations
12.
Erdag, Gulsun, Jochen T. Schaefer, Mark E. Smolkin, et al.. (2012). Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma. Cancer Research. 72(5). 1070–1080. 439 indexed citations
13.
Shada, Amber L., Lynn T. Dengel, Gina R. Petroni, et al.. (2012). Infrared thermography of cutaneous melanoma metastases. Journal of Surgical Research. 182(1). e9–e14. 52 indexed citations
14.
Slingluff, Craig L., Gina R. Petroni, Mark E. Smolkin, et al.. (2010). Immunogenicity for CD8+ and CD4+ T Cells of 2 Formulations of an Incomplete Freund's Adjuvant for Multipeptide Melanoma Vaccines. Journal of Immunotherapy. 33(6). 630–638. 24 indexed citations
15.
Slingluff, Craig L., Gina R. Petroni, Walter C. Olson, et al.. (2009). Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial. Clinical Cancer Research. 15(22). 7036–7044. 129 indexed citations
16.
Smith, Steven C., Matthew D. Nitz, Henry F. Frierson, et al.. (2009). Profiling Bladder Cancer Organ Site-Specific Metastasis Identifies LAMC2 as a Novel Biomarker of Hematogenous Dissemination. American Journal Of Pathology. 174(2). 371–379. 29 indexed citations
17.
Sullivan, Lisa, Mark E. Smolkin, Henry F. Frierson, & Mary T. Galgano. (2008). Comprehensive Evaluation of CDX2 in Invasive Cervical Adenocarcinomas. The American Journal of Surgical Pathology. 32(11). 1608–1612. 21 indexed citations
18.
Flury, Sarah C., Mary T. Galgano, Stacey E. Mills, Mark E. Smolkin, & Dan Theodorescu. (2007). Atypical small acinar proliferation: biopsy artefact or distinct pathological entity?. British Journal of Urology. 99(4). 780–785. 6 indexed citations
19.
Jones, David R., Thomas M. Daniel, Chadrick E. Denlinger, et al.. (2006). Stage IB Nonsmall Cell Lung Cancers: Are They All the Same?. The Annals of Thoracic Surgery. 81(6). 1958–1962. 40 indexed citations
20.
French, Amy J., Gina R. Petroni, Mark E. Smolkin, et al.. (2004). Allelic Imbalance of 8p Indicates Poor Survival in Gastric Cancer. Journal of Molecular Diagnostics. 6(3). 243–252. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John C. Morris Breakdown of academic impact, for papers by Pierpaolo Correale Breakdown of academic impact, for papers by Rohit Jain Breakdown of academic impact, for papers by Howard Streicher Breakdown of academic impact, for papers by Robert J. Hayashi Breakdown of academic impact, for papers by Manel Juan Breakdown of academic impact, for papers by Daniel H. Fowler Breakdown of academic impact, for papers by Kathleen M. Mahoney Breakdown of academic impact, for papers by Austin Miller Breakdown of academic impact, for papers by Santosha A. Vardhana
Rankless by CCL
2026